Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

3D virtual planning can help in precise skull reconstruction for advanced skin cancer, but patient-specific factors must be considered.

Growing human skin cells in a 3D environment can stimulate new hair growth.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Photodynamic therapy can remove nonpigmented hair in mice and might work for humans.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

CD99 is highly present in certain skin cells and could help treat skin conditions.

SOX2 is crucial for skin cell function and hair growth, and it plays a role in skin cancer and wound healing.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Alopecia areata in infants may be more common than previously thought.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Both mouse and rat models are effective for testing alopecia areata treatments.

Mice with human skin protein K8 had more skin problems and cancer.

Bioactive molecules show promise for improving skin repair and regeneration by overcoming current challenges with further research.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.